Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 2
2007 5
2008 5
2010 1
2012 1
2013 4
2014 3
2015 3
2016 4
2018 10
2019 2
2020 5
2021 6
2022 11
2023 19
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Carnosine and bone (Review).
Yang H, Hou X, Xing L, Tian F. Yang H, et al. Among authors: hou x. Mol Med Rep. 2023 Jan;27(1):12. doi: 10.3892/mmr.2022.12899. Epub 2022 Nov 23. Mol Med Rep. 2023. PMID: 36416346 Free PMC article. Review.
Impacts and mechanisms of PM2.5 on bone.
Tian Y, Hu Y, Hou X, Tian F. Tian Y, et al. Among authors: hou x. Rev Environ Health. 2023 Aug 3. doi: 10.1515/reveh-2023-0024. Online ahead of print. Rev Environ Health. 2023. PMID: 37527559 Review.
Acteoside improves adipocyte browning by CDK6-mediated mTORC1-TFEB pathway.
Sun Y, Ni X, Cheng S, Yu X, Jin X, Chen L, Yang Z, Xia D, Chen Z, Hu MG, Hou X. Sun Y, et al. Among authors: hou x. Biochim Biophys Acta Mol Cell Biol Lipids. 2023 Sep;1868(9):159364. doi: 10.1016/j.bbalip.2023.159364. Epub 2023 Jul 9. Biochim Biophys Acta Mol Cell Biol Lipids. 2023. PMID: 37433343
Protein succinylation: regulating metabolism and beyond.
Hou X, Chen Y, Li X, Gu X, Dong W, Shi J, Ji S. Hou X, et al. Front Nutr. 2024 Feb 6;11:1336057. doi: 10.3389/fnut.2024.1336057. eCollection 2024. Front Nutr. 2024. PMID: 38379549 Free PMC article. Review.
Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma.
Ren Z, Shao G, Shen J, Zhang L, Zhu X, Fang W, Sun G, Bai Y, Wu J, Liu L, Yuan Y, Zhang J, Li Z, Zhang L, Yin T, Wu J, Hou X, Wang Q, Zhu J, Fan J. Ren Z, et al. Among authors: hou x. Liver Cancer. 2022 Aug 30;12(2):116-128. doi: 10.1159/000526638. eCollection 2023 Jun. Liver Cancer. 2022. PMID: 37325495 Free PMC article.
83 results